Showing results (231-240 of 269) with videos related to

Sort By:
Pageof 27
Diabetes Technology & Therapeutics|June 28, 2022
WITHDRAWN: Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized TrialLaurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Diabetes Technology & Therapeutics|May 17, 2019
Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for HypoglycemiaStacey M Anderson, Bruce A Buckingham, Marc D Breton, et al.
Pediatric Diabetes|November 22, 2017
Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescentsGregory P Forlenza, Dan Raghinaru, Faye Cameron, et al.
Diabetes, Obesity & Metabolism|September 20, 2024
Psychosocial outcomes with the Omnipod® 5 Automated Insulin Delivery System in caregivers of very young children with type 1 diabetesSarah A MacLeish, Korey K Hood, William H Polonsky, et al.
Diabetes Technology & Therapeutics|September 29, 2022
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized TrialLaurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Plos One|November 13, 2020
Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCRFelipe de Jesus Cortez, David Gebhart, Peter V Robinson, et al.
The New England Journal of Medicine|August 27, 2020
A Randomized Trial of Closed-Loop Control in Children with Type 1 DiabetesMarc D Breton, Lauren G Kanapka, Roy W Beck, et al.
Pediatric Diabetes|April 30, 2025
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their CaregiversKorey K Hood, William H Polonsky, Sarah A MacLeish, et al.
Diabetes Care|December 23, 2020
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 DiabetesLauren G Kanapka, R Paul Wadwa, Marc D Breton, et al.
Nature Biomedical Engineering|May 13, 2020
A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigsCaitlin L Maikawa, Anton A A Smith, Lei Zou, et al.
Pageof 27